Cancer chemotherapy and biotherapy : principles and practice / Bruce A. Chabner, Dan L. Longo.
2011
RC271.C5 C32219 2011eb
Linked e-resources
Linked Resource
Details
Title
Cancer chemotherapy and biotherapy : principles and practice / Bruce A. Chabner, Dan L. Longo.
Edition
Fifth edition.
ISBN
9781605474311
Published
Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, [2011]
Copyright
©2011
Language
English
Description
1 online resource (836 pages) : illustrations.
Call Number
RC271.C5 C32219 2011eb
Dewey Decimal Classification
616.99/4061
Summary
"Updated to include the newest drugs and those currently in development, Cancer Chemotherapy and Biotherapy, Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents--their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Chapters emphasize pharmacology and mechanisms of action at the molecular and cellular levels, followed by clinical activity and toxicity, both acute and delayed. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. The previous edition was one of "Doody's Core Titles 2009." This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised"--Provided by publisher.
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Source of Description
Description based on print version record.
Added Author
Available in Other Form
Linked Resources
Record Appears in
Table of Contents
section I. Basic principles of cancer treatment
section II. Cytotoxic agents
section III. Molecularly targeted therapies
section IV. Immunologic agents
section V. Hormonal therapy
section VI. Supportive care
section VII. Survivorship.
section II. Cytotoxic agents
section III. Molecularly targeted therapies
section IV. Immunologic agents
section V. Hormonal therapy
section VI. Supportive care
section VII. Survivorship.